SQZ Biotechnologies Company (SQZ) financial statements (2022 and earlier)

Company profile

Business Address 200 ARSENAL YARDS BLVD., STE. 210
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments143,513170,357
Cash and cash equivalents143,513170,357
Receivables3,0001,892
Prepaid expense4,0274,032
Other undisclosed current assets95550
Total current assets:150,635176,831
Noncurrent Assets
Operating lease, right-of-use asset69,84348,360
Property, plant and equipment3,0463,645
Restricted cash and investments2,3052,305
Deferred costs323 
Total noncurrent assets:75,51754,310
TOTAL ASSETS:226,152231,141
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,78111,066
Accounts payable3,9713,708
Accrued liabilities6,8107,358
Deferred revenue12,50725,917
Other undisclosed current liabilities9,9368,210
Total current liabilities:33,22445,193
Noncurrent Liabilities
Long-term debt and lease obligation59,75638,885
Operating lease, liability59,75638,885
Liabilities, other than long-term debt9,19619,864
Deferred revenue9,19619,659
Other liabilities 205
Total noncurrent liabilities:68,95258,749
Total liabilities:102,176103,942
Stockholders' equity
Stockholders' equity attributable to parent123,976127,199
Common stock2825
Additional paid in capital319,458253,943
Accumulated deficit(195,510)(126,769)
Total stockholders' equity:123,976127,199
TOTAL LIABILITIES AND EQUITY:226,152231,141

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Revenues27,09820,998
Gross profit:27,09820,998
Operating expenses(95,867)(72,056)
Operating loss:(68,769)(51,058)
Nonoperating income28537
Investment income, nonoperating36550
Other nonoperating expense(8)(13)
Net loss available to common stockholders, diluted:(68,741)(50,521)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(68,741)(50,521)
Other comprehensive loss (30)
Comprehensive loss, net of tax, attributable to parent:(68,741)(50,551)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: